During the past decade, Kagoshima University Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kagoshima University Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Boston Scientific Japan K.K." with 1 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kagoshima University Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kagoshima University Hospital" are "Active Systemic Lupus Erythematosus" (1 trials), "Follicular Lymphoma" (1 trials), "Glioblastoma" (1 trials), "Lymphoma, Malignant" (1 trials) and "Marginal Zone Lymphoma" (1 trials). Many other conditions were trialed in "Kagoshima University Hospital" in a lesser frequency.

Most popular intervention types in "Kagoshima University Hospital" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo" (2 trials), "Apremilast" (1 trials), "Bevacizumab" (1 trials) and "DS-3201b" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kagoshima University Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kagoshima University Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kagoshima University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kagoshima University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".